151 related articles for article (PubMed ID: 37688482)
1. Recommendations on prevention of infections in patients with T-cell lymphomas: a narrative review and synthesis.
Reynolds G; Anderson MA; Thursky K; Teh BW; Slavin MA
Leuk Lymphoma; 2023 Dec; 64(13):2057-2070. PubMed ID: 37688482
[TBL] [Abstract][Full Text] [Related]
2. Ukrainian prospective study in patients with T-cell non-Hodgkin lymphomas.
Kriachok I; Shudrak N; Tytorenko I; Stepanishyna Y; Martynchik A; Aleksik O; Novosad O; Kadnikova T; Pastushenko Y; Kyschevoy E; Shokun N
Exp Oncol; 2021 Dec; 43(4):346-350. PubMed ID: 34967534
[TBL] [Abstract][Full Text] [Related]
3. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
4. Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009.
Kwong YL; Anderson BO; Advani R; Kim WS; Levine AM; Lim ST;
Lancet Oncol; 2009 Nov; 10(11):1093-101. PubMed ID: 19880063
[TBL] [Abstract][Full Text] [Related]
5. Uncommon non-Hodgkin lymphomas of childhood: pathological diagnosis, clinical features and treatment approaches.
Sandlund JT; Perkins SL
Br J Haematol; 2015 Jun; 169(5):631-46. PubMed ID: 25851546
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological analysis of 598 malignant lymphomas in Taiwan: seven-year experience in a single institution.
Lee MY; Tan TD; Feng AC; Liu MC
Am J Hematol; 2006 Aug; 81(8):568-75. PubMed ID: 16823825
[TBL] [Abstract][Full Text] [Related]
7. [Clinical analysis on 18 cases of primary nasal cavity and sinuses T/NK lymphomas].
Cui X; Liang C
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Nov; 18(11):651-2. PubMed ID: 15715405
[TBL] [Abstract][Full Text] [Related]
8. Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group.
Schmitz N; Trümper L; Ziepert M; Nickelsen M; Ho AD; Metzner B; Peter N; Loeffler M; Rosenwald A; Pfreundschuh M
Blood; 2010 Nov; 116(18):3418-25. PubMed ID: 20660290
[TBL] [Abstract][Full Text] [Related]
9. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
[TBL] [Abstract][Full Text] [Related]
10. Panniculitic primary cutaneous gamma delta T-cell lymphoma with concomitant features of autoimmune disease emphasizing a pathophysiologic continuum of lupus profundus with the panniculitic T cell lymphomas.
Magro CM; Kalomeris T; Dillard A
Clin Dermatol; 2023; 41(6):680-691. PubMed ID: 37716581
[TBL] [Abstract][Full Text] [Related]
11. Treatment algorithms for mature T-cell and natural killer-cell neoplasms.
Tse E; Kwong YL
Future Oncol; 2011 Sep; 7(9):1101-12. PubMed ID: 21919697
[TBL] [Abstract][Full Text] [Related]
12. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
Kato N; Yasukawa K; Onozuka T; Kikuta H
J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
[TBL] [Abstract][Full Text] [Related]
13. Classification of cytotoxic T-cell and natural killer cell lymphomas.
Jaffe ES; Krenacs L; Raffeld M
Semin Hematol; 2003 Jul; 40(3):175-84. PubMed ID: 12876666
[TBL] [Abstract][Full Text] [Related]
14. NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018.
Horwitz SM; Ansell SM; Ai WZ; Barnes J; Barta SK; Choi M; Clemens MW; Dogan A; Greer JP; Halwani A; Haverkos BM; Hoppe RT; Jacobsen E; Jagadeesh D; Kim YH; Lunning MA; Mehta A; Mehta-Shah N; Oki Y; Olsen EA; Pro B; Rajguru SA; Shanbhag S; Shustov A; Sokol L; Torka P; Wilcox R; William B; Zain J; Dwyer MA; Sundar H
J Natl Compr Canc Netw; 2018 Feb; 16(2):123-135. PubMed ID: 29439173
[TBL] [Abstract][Full Text] [Related]
15. Guidelines for the management of mature T- and natural killer-cell lymphomas (excluding cutaneous T-cell lymphoma): a British Society for Haematology Guideline.
Fox CP; Ahearne MJ; Pettengell R; Dearden C; El-Sharkawi D; Kassam S; Cook L; Cwynarski K; Illidge T; Collins G
Br J Haematol; 2022 Feb; 196(3):507-522. PubMed ID: 34811725
[No Abstract] [Full Text] [Related]
16. Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas/leukemias.
Cheung MM; Chan JK; Wong KF
Semin Hematol; 2003 Jul; 40(3):221-32. PubMed ID: 12876671
[TBL] [Abstract][Full Text] [Related]
17. Novel targeted therapies of T cell lymphomas.
Iżykowska K; Rassek K; Korsak D; Przybylski GK
J Hematol Oncol; 2020 Dec; 13(1):176. PubMed ID: 33384022
[TBL] [Abstract][Full Text] [Related]
18. Utility of PET/CT in the diagnosis and staging of extranodal natural killer/T-cell lymphoma: a systematic review and meta-analysis.
Zhou X; Lu K; Geng L; Li X; Jiang Y; Wang X
Medicine (Baltimore); 2014 Dec; 93(28):e258. PubMed ID: 25526450
[TBL] [Abstract][Full Text] [Related]
19. NK-cell intravascular lymphomatosis--a mini-review.
Nakamichi N; Fukuhara S; Aozasa K; Morii E
Eur J Haematol; 2008 Jul; 81(1):1-7. PubMed ID: 18462254
[TBL] [Abstract][Full Text] [Related]
20. High-dose therapy and autologous stem cell transplantation in Korean patients with aggressive T/NK-cell lymphoma.
Bang SM; Kim YK; Park YH; Sohn SK; Lee JJ; Cho EK; Ryoo BY; Chung IJ; Yoon SS; Kim HJ; Lee JH; Yoon HJ; Park S
Leuk Lymphoma; 2005 Nov; 46(11):1599-1604. PubMed ID: 16334486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
